Targeted gene delivery mediated by folate-polyethylenimine-block- poly(ethylene glycol) with receptor selectivity

Bioconjugate Chemistry

Volumn 20, Issue 3, 2009, Pages 481-487

  Cheng, Han ^a   Zhu, Jing Ling ^a   Zeng, Xuan ^a   Jing, Yue ^a   Zhang, Xian Zheng ^a   Zhuo, Ren Xi ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COPOLYMER; FOLATE POLYETHYLENIMINE BLOCK POLY(ETHYLENE GLYCOL); FOLATE RECEPTOR; FOLIC ACID; GREEN FLUORESCENT PROTEIN; LUCIFERASE; PLASMID DNA; UNCLASSIFIED DRUG; CARRIER PROTEIN; CELL SURFACE RECEPTOR; DNA; MACROGOL DERIVATIVE; POLYETHYLENEIMINE;

AGAR GEL ELECTROPHORESIS; ARTICLE; CELL STRAIN HEK293; CELL STRAIN HEPG2; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; RECEPTOR AFFINITY; ZETA POTENTIAL; ADMINISTRATION AND DOSAGE; CELL LINE; CELL SURVIVAL; CHEMISTRY; GENETICS; HELA CELL LINE; HEPG2 CELL LINE; METABOLISM; PLASMID;

CARRIER PROTEINS; CELL LINE; CELL SURVIVAL; DNA; FOLATE RECEPTORS, GPI-ANCHORED; FOLIC ACID; GREEN FLUORESCENT PROTEINS; HELA CELLS; HEP G2 CELLS; HUMANS; LUCIFERASES; PARTICLE SIZE; PLASMIDS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RECEPTORS, CELL SURFACE; TRANSFECTION;

EID: 63749131878     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc8004057     Document Type: Article

References (30)

1. El-Aneed, A. (2004) An overview of current delivery systems in cancer gene therapy. J. Controlled Release 94, 1-14.
2. Olefsky, J. M. (2000) Diabetes Gene therapy for rats and mice. Nature 408, 420-421.
3. Zhang, X. J., and Godbey, W. T. (2006) Viral vectors for gene delivery in tissue engineering. Adv. Drug Delivery Rev. 58, 515-534.
4. Song, S., Goudy, K., Campbell-Thompson, M., Wasserfall, C, Scott-Jorgensen, M., Wang, J., Tang, Q., Crawford, J. M., Ellis, T. M., Atkinson, M. A., and Flotte, T. R. (2004) Recombinant adeno-associated virusmediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice. Gene Ther. 11, 181-186.
5. Laporte, L. D., Rea, J. C, and Shea, L. D. (2006) Design of modular non-viral gene therapy vectors. Biomaterials 27, 941-954.
6. Merdan, T., Kopecek, J., and Kissel, T. (2002) Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv. Drug Delivery Rev. 54, 715-758.
7. Lehrman, S. (1999) Virus treatment questioned after gene therapy death. Nature 401, 517-518.
8. Gore, M. E. (2003) Adverse effects of gene therapy, gene therapy can cause leukaemia, no shock, mild horror but a probe. Gene Ther. 10, 4.
9. Sun, J. Y., Anand-Jawa, V., Chatterjee, S., and Wong, K. K. (2003) Immune responses to adeno-associated virus and its recombinant vectors. Gene Ther. 10, 964-976.
10. Liu, Q., and Muruve, D. A. (2003) Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther. 10, 935-940.
11. Kunath, K., von Harpe, A., Fischer, D., Peterson, H., Bickel, U., Voigt, K., and Kissel, T. (2003) Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery, comparison of physicochemical properties, transfection efficiency and in vivo distribution withhigh-molecular-weight polyethylenimine. J. Controlled Release 89, 113-125.
12. Itaka, K, Yamauchi, K., Harada, A., Nakamura, K, Kawagu-chi, H., and Kataoka, K. (2003) Polyion complex micelles from plasmid DNA and poly(ethyleneglycol)-poly(l-lysine) block copolymer as serum-tolerable polyplexsystem, physicochemical properties of micelles relevant to genetransfection efficiency. Biomaterials 24, 4495-4506.
13. Fischer, D., Bieber, T., Li, Y. X., Elsasser, H. P., and Kissel, T. (1999) A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res. 16, 1273-1279.
14. Tang, M. X., and Szoka, F. C. (1997) The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Ther. 4, 823-832.
15. Clamme, J. P., Azoulay, J., and Mely, Y. 2003) Monitoring of the formation and dissociation of polyethylenimine/DNA complexes by two photon fluorescence correlation spectrosco-pyBiophys. J. 84, 1960-1968.
16. Kichler, A., Leborgne, C, Coeytaux, E., and Danos, O. (2001) Polyethylenimine-mediated gene delivery: a mechanistic study. J. Gene. Med. 3, 135-144.
17. Petersen, H., Fechner, P. M., Martin, A. L., Kunath, K, Snjezana, S., Roberts, C. J., Martin, A. L., and Kunath, K. (2002) Polyemylenimine-gra//- poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjugate Chem. 13, 845-854.
18. Harada-Shiba, M., Yamauchi, K, Harada, A., Takamisawa, I., Shimokado, K., and Kataoka, K. (2002) Polyion complex micelles as vectors in gene therapy-pharmacokinetics and in vivo gene transfer. Gene Ther. 9, 407-414.
19. Petersen, H., Fechner, P. M., Fischer, D., and Kissel, T. (2002) Synthesis, characterization, and biocompatibility of polyethyl-enimine-graft- poly(ethylene glycol) block copolymers. Macro-molecules 35, 6867-6874.
20. Brus, C, Petersen, H., Aigner, A., Czubayko, F., and Kissel, T. (2004) Physicochemical and biological characterization of polyethylenimine-graft- poly(ethylene glycol) block copolymers as a delivery system for oligonucleotides and ribozymes. Bioconjugate Chem. 15, 677-684.
21. Guo, W. J., and Lee, R. J. (1999) Receptor-targeted gene delivery via folate-conjugated polyethylenimine. AAPS PharmSci. 1, E19.
22. Liang, B., He, M. L., Xiao, Z. P., Li, Y., Chan, C, Kung, H. F., Shuai, X. T., and Peng, Y. (2008) Synthesis and characterization of folate-PEG-grafted-hyperbranched-PEI for tumor-targeted gene delivery. Biochem. Biophys. Res. Commun. 367, 874-880.
23. Liu, S. Q., Wiradharma, N., Gao, S. J., Tong, Y. W., and Yang, Y. Y. (2007) Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials 28, 1423-1433.
24. Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum-Shavit, F., Qazen, M. M., and Zalipsky, S. (1999) Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjugate Chem. 10, 289-298.
25. Bozkir, A., and Saka, O. M. (2004) Chitosan-DNA nanopar-ticles: effect on DNA integrity, bacterial transformation and transfection efficiency. J. Drug Target 12, 281-288.
26. Avgoustakis, K. (2004) Pegylated poly(lactide) and poly(lac-tide-co- glycolide) nanoparticles: preparation, properties and possible applications in drug delivery. Curr. Drug Delivery 1, 321-333.
27. Mansouri, S., Cuie, Y., Winnik, F., Shi, Q., Lavigne, P., Benderdour, M., Beaumont, E., and Fernandes, J. C. (2006) Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials 27, 2060-2065.
28. Clements, B. A., Bai, J., Kucharski, C, Farrell, L. L., Lavasanifar, A., Ritchie, B., Ghahary, A., and Uludag, H. (2006) RGD conjugation to polyethyleneimine does not improve DNA delivery to bone marrow stromal cells. Biomacromolecules 7, 1481-1488.
29. Conwell, C. C, and Huang, L. (2005) Recent advances in non-viral gene delivery. Adv. Genet. 53, 1-18.
30. Deery, E. C, Vithana, E. N., Newbold, R. J., Gallon, V. A., Bhattacharya, S. S., Warren, M. J., Hunt, D. M., and Wilkie, S. E. (2002) Disease mechanism for retinitis pigmentosa (RP11) caused by mutations in the splicing factor gene PRPF31. Hum. Mol. Genet. 11, 3209-3219.